US · Healthcare · Medical Instruments & Supplies
EPS came in at -0.07 against a street estimate of -0.11 — a beat of 36.4%.
Analysts rate AngioDynamics Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $20.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.92% |
| Point72 Asset Management, L.P. | 7.70% |
| Systematic Financial Management LP | 5.94% |
| Armistice Capital, LLC | 4.52% |
| Broadfin Holdings LLC | 4.40% |
| Vanguard Capital Management, LLC | 4.18% |
| Royce & Associates, LP | 3.70% |
| Weber Capital Management LLC | 3.28% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for AngioDynamics Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.